Through both polygenic and monogenic approaches, the CAD PRS model was helpful in SCDCAD risk stratification and SCD-related rare variants in the MUC19 and CGN genes could be considered as potential biomarkers of SCDCAD. Here, CGN is linked to coronary artery disorder.